Bank of New York Mellon »

Avita Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 108k 16.03
2023-12-31 $1.6M 117k 13.72
2023-09-30 $1.9M 128k 14.61
2023-06-30 $2.0M 116k 17.01
2023-03-31 $792k 57k 13.97
2022-12-31 $373k 57k 6.60
2022-09-30 $300k 57k 5.31
2022-06-30 $269k 57k 4.75
2022-03-31 $902k 106k 8.48
2021-12-31 $874k 73k 11.98
2021-09-30 $1.3M 72k 17.74
2021-06-30 $1.2M 60k 20.52
2021-03-31 $234k 12k 19.82
2020-12-31 $242k 13k 18.58
2020-09-30 $233k 9.2k 25.19